Voriconazole (UK-109496) is a second-generation, broad-spectrum triazole antifungal agent that inhibits fungal ergosterol biosynthesis. Voriconazole exerts its antifungal activity by inhibition of 14-α-lanosterol demethylation, which is mediated by fungal cytochrome P450 enzymes[1][2].
性状
固体
体外研究(In Vitro)
Voriconazole 对 S. apiospermum 和 C. neoformans 具有很强的活性,MIC 分别为 0.5 μg/mL 和 0.125-0.25 μg/mL[1]。
Voriconazole 抑制细胞色素 P450 (CYP) 依赖性酶 14-α-甾醇脱甲基酶,从而破坏细胞膜并阻止真菌生长[2]。